USPTO serial 79458982
Reviewed by CopyMark Law Group
Status 630 means your trademark application is in the USPTO queue and has not yet been assigned to an examining attorney. This is normal shortly after filing. Examination typically begins within three to four months, though timing varies. Wait for assignment and the first examiner action. Monitor TSDR monthly for status changes to 638 (assigned) or an office action.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical and biochemical preparations for use in research and laboratories, in particular reagents for pharmacological research, chemical reagents for chromatographic immobilization, purification or isolation of biological materials; chemical reagents for chromatographic immobilization, purification or isolation of cells, in particular body cells and cells of the immune system of mammals including human cells; affinity chromatography reagents used in columns for immobilization, purification or isolation of cells, in particular for immobilization or purification of body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and moncytes; chemical reagents for genetically modifying body cells, stem cells and cells of the immune system of mammals including human cells, T-cells, B-cells, natural killer cells and monocytes; chemical reagents for transferring genes into body cells, stem cells, and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes. | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations, in particular cells, in particular body cells, stem cells, and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; body cells, stem cells, and cells of the immune systems for treatment of cancerous diseases, autoimmune diseases, viral infections or bacterial infections, genetically modified human immune cells, including T-cells, B-cells, natural killer cells or monocytes for treatment of cancerous diseases, autoimmune diseases, viral infections or bacterial infections, in vivo diagnostic reagents for medical purposes. | ACTIVE | — |
| 009 | Scientific apparatus for the chromatographic immobilization, purification or isolation of biological materials; chromatography columns; scientific apparatus for the chromatographic immobilization, purification or isolations of cells, in particular body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes; scientific apparatus for the transfer of genes into body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes. | ACTIVE | — |
| 042 | Scientific services and research relating thereto in the fields of biology, chemistry, medicine, immunology, oncology, molecular biology, cellular biology, biochemistry and/or medicinal chemistry as well as in the fields of discovery and development of pharmaceuticals, medical and veterinary preparations, in particular cellular therapy products, including body cells, stem cells and cells of the immune system of mammals including human cells and T-cells, B-cells, natural killer cells and monocytes, diagnostic preparations and biomarker reagents and/or diagnostic apparatus. | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 25, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 25, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 24, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |